Comparisons11 min readUpdated 2025-12-02

    Switching from MedVi to Trimi

    A step-by-step guide to switching from MedVi's AI-powered platform to Trimi's physician-led GLP-1 treatment. Learn how to transition seamlessly, save money, and get specialized metabolic health care.

    Why Patients Switch from MedVi

    Significant cost savings: Trimi's $99/mo vs MedVi's $149-$349/mo — especially at premium AI tiers

    Proven physician expertise: Board-certified metabolic health specialists with established clinical track records

    Transparent pricing: No tiered AI features or confusing plan structures — one price includes everything

    Higher pharmacy standards: 503A sterile compounding pharmacy partnerships vs standard compounding

    Faster delivery: 5-7 days vs 7-14 days

    No contracts: Month-to-month flexibility instead of commitment requirements

    Step-by-Step Switching Guide

    Step 1: Check your remaining MedVi supply — aim for 1-2 weeks of medication before starting the switch.

    Step 2: Gather treatment details — current medication, dose, duration, side effects, and progress.

    Step 3: Complete Trimi's online assessment (10-15 minutes). Include your MedVi treatment history.

    Step 4: Board-certified provider reviews within 24-48 hours and creates your continuation plan.

    Step 5: Medication ships from 503B pharmacy with free delivery (5-7 days).

    Step 6: Cancel MedVi after Trimi medication arrives. See our MedVi cancellation guide.

    Savings Comparison

    FactorMedViTrimi
    Monthly Cost$149 - $349/moFrom $99/mo
    ConsultationsVaries by tierIncluded
    ShippingVariesFree
    Annual Savings$0 - $2,400+ per year
    ContractSome plansNone

    What to Expect During Transition

    The transition is medically straightforward — you are continuing the same compounded GLP-1 medication. Moving from AI-managed to physician-managed care does not affect the medication's efficacy. Many patients find that Trimi's specialized physicians identify optimization opportunities that improve their treatment experience, including refined side effect management and more individualized dose titration.

    Transition Tip

    Start the Trimi process with at least 2 weeks of MedVi supply remaining. This ensures comfortable overlap and eliminates any treatment gap risk.

    Bottom Line

    Switching from MedVi to Trimi is straightforward, typically completed within one week, and delivers immediate benefits in cost savings and specialized care. If you have been considering the switch, visit Trimi to start your assessment. For more context, see our MedVi vs Trimi comparison and MedVi cancellation guide.

    Frequently Asked Questions

    Can I switch from MedVi without a treatment gap?

    Yes. Start Trimi's evaluation while you still have 1-2 weeks of MedVi medication. Trimi typically delivers within 5-7 days of approval, enabling smooth transitions.

    Will I lose progress switching from AI to physician-led care?

    No. You are continuing the same compounded GLP-1 medication. Trimi's specialized physicians may actually identify optimization opportunities that enhance your progress.

    Will Trimi continue my MedVi dosage?

    In most cases, yes. Trimi providers independently evaluate your treatment history and typically continue effective dosing. They may also recommend adjustments based on their metabolic health expertise.

    How much will I save switching?

    Patients on MedVi premium plans ($249-$349/mo) switching to Trimi ($99/mo) save $100-$200/mo, translating to $1,200-$2,400+ annually.

    Should I cancel MedVi before starting Trimi?

    No. Complete Trimi's evaluation and confirm medication shipment first. Cancel MedVi only after your new supply is secured.

    Is physician-led care as good as AI-powered?

    Physician-led care has decades of clinical evidence supporting its effectiveness. Board-certified metabolic health specialists bring training, experience, and judgment that AI tools are still developing. Most patients find physician-led care equally or more effective.

    How long does switching take?

    About one week. Trimi's assessment takes 10-15 minutes, provider review occurs within 24-48 hours, and medication ships within 5-7 days.

    Sources & References

    1. MedVi. Official Website and Terms. 2025-2026.
    2. STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
    3. FDA guidance on compounding and the FDA.
    4. American Telemedicine Association. Telehealth Practice Guidelines. 2025.
    5. Wegovy prescribing information from the FDA.
    6. National Association of Boards of Pharmacy. Standards. 2025.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Trimi is a competitor to MedVi — this guide aims to be fair and balanced, but readers should be aware of our perspective.

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: December 2, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Practical guide to canceling WeightWatchers (formerly Sequence) GLP-1 program and switching to Trimi: prescription transfer steps, dose continuity considerations, billing cutover, and how Trimi's flat $99/mo simplifies the cost equation.

    Step-by-step guide to canceling Ro Body and switching to Trimi: how to time the prescription transfer, maintain dose continuity, avoid double-billing, and lock in Trimi's flat $99/mo semaglutide or $125/mo tirzepatide pricing.

    Complete guide covering how weight loss injections are available at $99 per month in 2026. Compare options, understand pricing, and discover how compounded GLP-1 medications deliver the same active in

    Step-by-step guide to canceling TrimRx, navigating the process, and transitioning to Trimi for more affordable, physician-led GLP-1 treatment with transparent pricing and no contracts.

    Start your GLP-1 journey — from $99/mo

    Get Started